Survivin is a therapeutic target in Merkel cell carcinoma.

@article{Arora2012SurvivinIA,
  title={Survivin is a therapeutic target in Merkel cell carcinoma.},
  author={Reety Arora and Masahiro Shuda and Anna Guastafierro and Huichen Feng and Tuna Toptan and Yanis Tolstov and Daniel P Normolle and Laura L. Vollmer and Andreas Vogt and Alexander S. D{\"o}mling and Jeffrey L Brodsky and Yuan - Chia Chang Yeun - Chung Chang Chin - Chen Chang and Patrick S Moore},
  journal={Science translational medicine},
  year={2012},
  volume={4 133},
  pages={133ra56}
}
Merkel cell polyomavirus (MCV) causes ~80% of primary and metastatic Merkel cell carcinomas (MCCs). By comparing digital transcriptome subtraction deep-sequencing profiles, we found that transcripts of the cellular survivin oncoprotein [BIRC5a (baculoviral inhibitor of apoptosis repeat-containing 5)] were up-regulated sevenfold in virus-positive compared to virus-negative MCC tumors. Knockdown of MCV large T antigen in MCV-positive MCC cell lines decreased survivin mRNA and protein expression… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 59 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Sasamata, YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts

  • T. Nakahara, M. Takeuchi, +7 authors M. M. Kudoh
  • Cancer Res
  • 2007
Highly Influential
4 Excerpts

A virus-induced human cancer

  • Y. Chang, P. S. Moore, Merkel cell carcinoma
  • Annu. Rev. Pathol. 7, 123–144
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…